Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dummer

Showing results (201-210 of 328) with videos related to

Pageof 33
Sort By:
Praxis|July 20, 2012
[Therapeutic approaches in Melanoma - a paradigm for personalized medicine]R Dummer, S Goldinger, J Rinderknecht, et al.
International Journal of Cancer|May 16, 1997
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 moleculesF Y Yue, R Dummer, R Geertsen, et al.
Archives of Dermatological Research|January 1, 1993
UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytesR Dummer, J C Meyer, B K Ballmer-Weber, et al.
European Journal of Immunology|June 26, 1999
IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?F Y Yue, R Geertsen, S Hemmi, et al.
Melanoma Research|September 14, 2000
Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?F Y Yue, L Cao, S Hemmi, et al.
Dermatology (Basel, Switzerland)|October 26, 2002
Prevention campaign against skin cancerL M Heinzerling, R Dummer, R G Panizzon, et al.
The British Journal of Dermatology|June 20, 2002
T-zone lymphoma with cutaneous involvement: a case report and review of the literatureD V Kazakov, W Kempf, S Michaelis, et al.
The Journal of Investigative Dermatology|September 18, 1998
Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesionsR C Geertsen, G F Hofbauer, F Y Yue, et al.
Archives of Physical Medicine and Rehabilitation|August 18, 2021
Combining the AM-PAC "6-Clicks" and the Morse Fall Scale to Predict Individuals at Risk for Falls in an Inpatient Rehabilitation HospitalKeith R Lohse, Danica R Dummer, Heather A Hayes, et al.
The British Journal of Dermatology|July 24, 2004
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipientsG Dragieva, B M Prinz, J Hafner, et al.
Pageof 33

Showing results (201-210 of 328) with videos related to

Sort By:
Pageof 33
Praxis|July 20, 2012
[Therapeutic approaches in Melanoma - a paradigm for personalized medicine]R Dummer, S Goldinger, J Rinderknecht, et al.
International Journal of Cancer|May 16, 1997
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 moleculesF Y Yue, R Dummer, R Geertsen, et al.
Archives of Dermatological Research|January 1, 1993
UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytesR Dummer, J C Meyer, B K Ballmer-Weber, et al.
European Journal of Immunology|June 26, 1999
IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?F Y Yue, R Geertsen, S Hemmi, et al.
Melanoma Research|September 14, 2000
Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?F Y Yue, L Cao, S Hemmi, et al.
Dermatology (Basel, Switzerland)|October 26, 2002
Prevention campaign against skin cancerL M Heinzerling, R Dummer, R G Panizzon, et al.
The British Journal of Dermatology|June 20, 2002
T-zone lymphoma with cutaneous involvement: a case report and review of the literatureD V Kazakov, W Kempf, S Michaelis, et al.
The Journal of Investigative Dermatology|September 18, 1998
Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesionsR C Geertsen, G F Hofbauer, F Y Yue, et al.
Archives of Physical Medicine and Rehabilitation|August 18, 2021
Combining the AM-PAC "6-Clicks" and the Morse Fall Scale to Predict Individuals at Risk for Falls in an Inpatient Rehabilitation HospitalKeith R Lohse, Danica R Dummer, Heather A Hayes, et al.
The British Journal of Dermatology|July 24, 2004
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipientsG Dragieva, B M Prinz, J Hafner, et al.
Pageof 33